Healthcare / Medical Care FacilitiesNYSE
$62.52
-0.00 (-0.01%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 21% · confianza 25%
FCF escenarios
weak_data · normalized FCF $65.8M · quality 80.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$952M
P/E
125.0x
↑EV/EBITDA
11.2x
↓ROE
3.2%
↑Gross Margin
19.2%
↓Debt/Equity
0.66
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
+8.8%
FCF CAGR
—
FCF margin
7.8%
FCF / Net income
4.05x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $781.0M · net income $15.1M · FCF $61.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $781.0M | $781.0M | $671.3M | $604.8M | $553.1M | $495.0M | $423.0M | $482.0M | $453.9M | $414.1M | $356.5M | $331.3M | $305.1M | $264.1M | $249.7M | $231.5M | $211.2M | $201.4M |
| Net Income | $15.1M | $15.1M | $26.5M | $14.7M | $28.3M | $40.8M | $35.2M | $40.0M | $34.9M | $22.3M | $20.6M | $20.6M | $19.1M | $12.7M | $17.9M | $21.0M | $15.6M | $11.8M |
| EBITDA | $109.7M | $109.7M | $86.9M | $74.4M | $76.1M | $82.2M | $62.9M | $77.5M | $70.1M | $64.4M | $58.3M | $55.2M | $52.5M | $44.3M | $43.7M | $36.9M | $38.9M | $34.1M |
| EPS | 1.42 | 1.42 | 1.84 | 1.28 | 2.25 | 2.41 | 2.48 | 2.45 | — | — | — | 1.77 | 1.62 | 1.05 | 1.51 | 1.75 | 1.32 | 1.00 |
| Gross Margin | 19.2% | 19.2% | 18.5% | 20.1% | 20.3% | 23.7% | 22.3% | 23.3% | 22.4% | 21.9% | 23.0% | 23.7% | 25.0% | 24.5% | 25.2% | 24.1% | 26.5% | — |
| Operating Margin | 10.3% | 10.3% | 9.8% | 11.6% | 11.9% | 14.3% | 12.4% | 14.0% | 13.3% | 13.2% | 13.9% | 14.3% | 15.0% | 14.7% | 15.4% | 13.6% | 15.7% | 14.0% |
| Net Margin | 1.9% | 1.9% | 3.9% | 2.4% | 5.1% | 8.2% | 8.3% | 8.3% | 7.7% | 5.4% | 5.8% | 6.2% | 6.3% | 4.8% | 7.2% | 9.1% | 7.4% | 5.8% |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 0.66 | 0.66 | 0.60 | 0.54 | 0.94 | 0.40 | 0.06 | 0.21 | 0.18 | 0.28 | 0.27 | 0.28 | 0.24 | 0.32 | 0.15 | 0.22 | — | — |
| Current Ratio | 1.19 | 1.19 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $61.0M | $61.0M | $65.8M | $72.7M | $50.3M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Returns | ||||||||||||||||||
| ROE | 3.2% | 3.2% | 5.4% | 3.1% | 9.0% | 13.8% | 12.7% | 16.7% | 16.1% | 10.9% | 11.0% | 12.1% | 13.1% | 9.9% | 15.3% | 19.6% | 15.0% | — |
| Valuation | ||||||||||||||||||
| P/E | 125.05 | 125.05 | 47.92 | 72.49 | 37.49 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 11.20 | 11.20 | 18.21 | 19.12 | 17.86 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.99 | 1.99 | 2.72 | 2.76 | 3.47 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | 16.3% | 16.3% | 11.0% | 9.3% | — | 17.0% | -12.2% | 6.2% | 9.6% | 16.1% | 7.6% | 8.6% | 15.5% | 5.8% | 7.8% | 9.6% | 4.9% | — |
| EPS Growth | -22.8% | -22.8% | 43.8% | -43.1% | — | -2.8% | 1.2% | — | — | — | — | 9.3% | 54.3% | -30.5% | -13.7% | 32.6% | 32.0% | — |
| Dividend Yield | 2.9% | 2.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
57.5%
EPS terminal req.
$5.55
Spread vs growth
-80.3%
5Y implied EPS CAGR
36.4%
EPS terminal req.
$6.71
Spread vs growth
-59.3%
10Y implied EPS CAGR
22.5%
EPS terminal req.
$10.81
Spread vs growth
-45.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-12.8%
Start / end P/E
40.3x → 44.0x
EPS bridge
1.84 → 1.42
Residual
-2.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.